NDC 73309-303-01 - Sevelamer Carbonate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-303
- Requested NDC
- 73309-303-01
- Package NDCs from labels
- 73309-303-01
- Manufacturer
- Bluebay Shangdong Co.,LTD
- Effective date
- 2021-06-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sevelamer Carbonate - Bluebay Shangdong Co.,LTD | Bluebay Shangdong Co.,LTD | 2021-06-17 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-303-01 | Sevelamer Carbonate | 500 g in 1 JAR | POWDER | 500 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sevelamer Carbonate | SEVELAMER CARBONATE | Bryant Ranch Prepack | 462a11b9-78a3-4d8b-ae5d-3d6528e4d743 | 2026-08-27 | Warnings, Adverse reactions | 9YCX42I8IU |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | NorthStar RxLLC | 5baf3742-5929-42f8-8865-6b3e92647d5b | 2026-07-16 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Macleods Pharmaceuticals Limited | 4c927d50-34a6-499b-b1c2-924d4eb73987 | 2026-07-10 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Marp Pharma | 515ae758-ccba-5758-e063-6394a90a315b | 2026-06-17 | Warnings, Adverse reactions | 9YCX42I8IU |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | INSIGNAMEDEX LLC | 51ce2ed6-3acf-a6ea-e063-6294a90a21aa | 2026-05-22 | Warnings, Adverse reactions | 9YCX42I8IU |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | PD-Rx Pharmaceuticals, Inc. | b72baeeb-b6f5-4fa1-bee8-9eb4bb74dc82 | 2026-04-17 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer carbonate | SEVELAMER CARBONATE | Zydus Pharmaceuticals USA Inc. | 2ccf62c6-dbad-416d-8e02-631795bd7517 | 2026-03-18 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | AvPAK | 7f701cb4-3089-375f-e053-2991aa0a51b9 | 2026-01-20 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer carbonate | SEVELAMER CARBONATE | Navinta LLC | d2f0c283-3e9d-41db-bd4d-83bd21f2a019 | 2026-01-01 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Cardinal Health 107, LLC | 65184825-adce-480e-a4c3-b21e37656cf4 | 2025-12-19 | Warnings, Adverse reactions | 9YCX42I8IU |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | Shandong Xinhua Pharmaceutical Co., Ltd. | f6455fa3-ad53-f6fd-e053-2a95a90a67db | 2025-12-15 | Warnings, Adverse reactions | 9YCX42I8IU |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | AiPing Pharmaceutical, Inc. | 0cade89a-38ca-4072-97a0-be09c6e058f4 | 2025-12-04 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Sanofi-Aventis U.S. LLC | 3abc32fe-1bfc-4759-8f7c-36095e221b06 | 2025-11-25 | Warnings, Adverse reactions | 9YCX42I8IU |
| Renvela | SEVELAMER CARBONATE | Genzyme Corporation | e6328460-a57b-450b-a48c-6dcd4b476360 | 2025-11-25 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Major Pharmaceuticals | 42fefb90-6941-4539-8f32-df1896223450 | 2025-11-13 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | AvKARE | 41890246-efa5-524a-e063-6294a90a5ad9 | 2025-10-19 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Westminster Pharmaceuticals, LLC | 45a955e9-94ac-48db-838c-74934eae245b | 2025-10-01 | Warnings, Adverse reactions | 9YCX42I8IU |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | Macleods Pharmaceuticals Limited | 48dbd7a7-32c7-45c1-ac8b-c478cf3282a6 | 2025-09-26 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Precision Dose, Inc. | 09b5e422-18c9-49dc-be3d-5d24648184af | 2025-08-11 | Warnings, Adverse reactions | 9YCX42I8IU |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | Strides Pharma Science Limited | 649e5b7b-aa2f-4975-8c00-01d647d35c01 | 2025-07-17 | Warnings, Adverse reactions | 9YCX42I8IU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.